Cargando…

Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015

BACKGROUND: Extracorporeal liver support therapies (ELS) are technical options (for bridge-to-recovery as well as bridge-to-transplant) in patients with acute liver dysfunction (e.g. acute liver failure (ALF), acute-on chronic liver failure (AoCLF) or decompensated chronic liver disease (decomp. CLD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiesmann, Thomas, Hoenl, Dominic, Wulf, Hinnerk, Irqsusi, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724268/
https://www.ncbi.nlm.nih.gov/pubmed/31481009
http://dx.doi.org/10.1186/s12876-019-1077-y
_version_ 1783448954421116928
author Wiesmann, Thomas
Hoenl, Dominic
Wulf, Hinnerk
Irqsusi, Marc
author_facet Wiesmann, Thomas
Hoenl, Dominic
Wulf, Hinnerk
Irqsusi, Marc
author_sort Wiesmann, Thomas
collection PubMed
description BACKGROUND: Extracorporeal liver support therapies (ELS) are technical options (for bridge-to-recovery as well as bridge-to-transplant) in patients with acute liver dysfunction (e.g. acute liver failure (ALF), acute-on chronic liver failure (AoCLF) or decompensated chronic liver disease (decomp. CLD)) to reduce effects of failing hepatic detoxification functions. The present study investigates the real-life utilization of ELS (annual incidences), mortality rates as well as data regarding specific populations of liver transplantation in Germany. METHODS: Data on patient cases receiving extracorporeal liver support therapy were identified in a nationwide data set from the Federal statistical Office of Germany from 1 January 2007 through 31 December 2015 and analyzed regarding in-hospital mortality, age- and sex-specific distribution and use of ELS in the context of liver transplantation. Mortality rates in patients with primary acute liver dysfunction and secondary acute liver dysfunction (in the context of cardiothoracic surgery) were evaluated. RESULTS: Annual incidences of ELS use remained stable between 0.39/100.000 in 2007 and 0.47/100.000 ELS in 2015. In-hospital mortality rate was 51.49% in the 2886 evaluated patient cases. Mortality was higher in men (56.04%) than in women (43.70) in the observed time period between 2007 and 2015. ELS utilization and case-related liver transplantation rates were low (12.47%). Since 2012, the annual numbers for ELS therapy in cardiosurgical patients exceeded the frequency of ELS utilization in cases of primary liver dysfunction (mortality rates: 68.39% versus 40.63%). CONCLUSIONS: ELS utilization remained stable between 2007 and 2015. Mortality rates are high in this patient population of acute liver dysfunction, especially in combination with case-related cardiothoracic surgery. ELS is rarely used in the setting of liver transplantation. In 2015, more than 50% of all ELS cases in Germany were performed in the context of cardiothoracic surgery.
format Online
Article
Text
id pubmed-6724268
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67242682019-09-10 Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 Wiesmann, Thomas Hoenl, Dominic Wulf, Hinnerk Irqsusi, Marc BMC Gastroenterol Research Article BACKGROUND: Extracorporeal liver support therapies (ELS) are technical options (for bridge-to-recovery as well as bridge-to-transplant) in patients with acute liver dysfunction (e.g. acute liver failure (ALF), acute-on chronic liver failure (AoCLF) or decompensated chronic liver disease (decomp. CLD)) to reduce effects of failing hepatic detoxification functions. The present study investigates the real-life utilization of ELS (annual incidences), mortality rates as well as data regarding specific populations of liver transplantation in Germany. METHODS: Data on patient cases receiving extracorporeal liver support therapy were identified in a nationwide data set from the Federal statistical Office of Germany from 1 January 2007 through 31 December 2015 and analyzed regarding in-hospital mortality, age- and sex-specific distribution and use of ELS in the context of liver transplantation. Mortality rates in patients with primary acute liver dysfunction and secondary acute liver dysfunction (in the context of cardiothoracic surgery) were evaluated. RESULTS: Annual incidences of ELS use remained stable between 0.39/100.000 in 2007 and 0.47/100.000 ELS in 2015. In-hospital mortality rate was 51.49% in the 2886 evaluated patient cases. Mortality was higher in men (56.04%) than in women (43.70) in the observed time period between 2007 and 2015. ELS utilization and case-related liver transplantation rates were low (12.47%). Since 2012, the annual numbers for ELS therapy in cardiosurgical patients exceeded the frequency of ELS utilization in cases of primary liver dysfunction (mortality rates: 68.39% versus 40.63%). CONCLUSIONS: ELS utilization remained stable between 2007 and 2015. Mortality rates are high in this patient population of acute liver dysfunction, especially in combination with case-related cardiothoracic surgery. ELS is rarely used in the setting of liver transplantation. In 2015, more than 50% of all ELS cases in Germany were performed in the context of cardiothoracic surgery. BioMed Central 2019-09-03 /pmc/articles/PMC6724268/ /pubmed/31481009 http://dx.doi.org/10.1186/s12876-019-1077-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wiesmann, Thomas
Hoenl, Dominic
Wulf, Hinnerk
Irqsusi, Marc
Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
title Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
title_full Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
title_fullStr Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
title_full_unstemmed Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
title_short Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
title_sort extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724268/
https://www.ncbi.nlm.nih.gov/pubmed/31481009
http://dx.doi.org/10.1186/s12876-019-1077-y
work_keys_str_mv AT wiesmannthomas extracorporealliversupporttrendingepidemiologyandmortalityanationwidedatabaseanalysis20072015
AT hoenldominic extracorporealliversupporttrendingepidemiologyandmortalityanationwidedatabaseanalysis20072015
AT wulfhinnerk extracorporealliversupporttrendingepidemiologyandmortalityanationwidedatabaseanalysis20072015
AT irqsusimarc extracorporealliversupporttrendingepidemiologyandmortalityanationwidedatabaseanalysis20072015